HIGH

Chlorpromazine Hydrochloride Tablets Recalled Over Foreign Substance Found in Packaging Coil (High-R

Chlorpromazine Hydrochloride tablets distributed nationwide by American Health Packaging are recalled after a polyester coil used in packaging showed presence of a micro-organism in a specific lot. No tablets were contaminated. Consumers and healthcare providers should stop using this product immediately and contact Amerisource Health Services LLC for guidance.

Quick Facts at a Glance

Recall Date
August 27, 2025
Hazard Level
HIGH
Brands
Chlorpromazine Hydrochloride, American Health Packaging
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL, PREGNANT, PREGNANT

Hazard Information

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging at the manufacturing site, was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amerisource Health Services LLC or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Chlorpromazine hydrochloride is an antipsychotic medication used to treat certain psychiatric conditions. It is distributed to healthcare facilities and pharmacies.

Why This Is Dangerous

A foreign substance from packaging coil carried a microorganism. Tablets themselves were free of microorganisms.

Industry Context

This recall is not part of a broader pattern at this time.

Real-World Impact

No injuries reported. Consumers should stop using the affected lots and await guidance.

Practical Guidance

How to identify if yours is affected

  1. Check carton NDC: 60687-452-01
  2. Check blister NDC: 60687-452-11
  3. Confirm lot numbers 1021652, 1022539, 1023666 and exp dates
  4. Look for packaging material: auxiliary polyester coil presence

Where to find product info

FDA recall page D-0649-2025 and enforcement reports

What timeline to expect

Refund or replacement notification via letter; timeline not specified

If the manufacturer is unresponsive

  • File a report with FDA recall program
  • Contact healthcare provider for interim guidance
  • Keep records of correspondence

How to prevent similar issues

  • Verify packaging certification and supplier quality controls
  • Report packaging issues to the pharmacy or manufacturer
  • Stay updated with FDA recall notices

Documentation advice

Save recall letter, take photos of packaging and lot codes

Product Details

Product: Chlorpromazine Hydrochloride Tablets, USP 100 mg. Packaging: 100 tablets per carton, 10x10 blister packs. Distribution: Nationwide in the USA. Distributor: American Health Packaging, Columbus, OH. Carton NDC: 60687-452-01. Individual NDC: 60687-452-11. Quantity recalled: 1,757 cartons. Lot numbers and expirations in use: 1021652 (Exp 10/31/2026), 1022539 (Exp 01/31/2027), 1023666 (Exp 03/31/2027).

Reported Incidents

No injuries reported. The hazard is contamination risk; no patient injuries documented in the recall notice.

Key Facts

  • Queen: 1,757 cartons recalled
  • Lot numbers: 1021652, 1022539, 1023666
  • Expirations: 10/31/2026; 01/31/2027; 03/31/2027
  • NDC: 60687-452-01 (carton); 60687-452-11 (individual blister)
  • Distributor: American Health Packaging
  • Country of origin: Unknown

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERALPREGNANTPREGNANTPETS
Injury Types
OTHERPOISONINGLACERATION

Product Details

Model Numbers
Lot: 1021652
Lot: 1022539
Lot: 1023666
UPC Codes
60687-419
60687-430
60687-441
+12 more
Affected States
ALL
Report Date
September 24, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more